Top Markets
#1 ADO Protocol ADO Protocol +337.09%
#2 GoPlus Security GoPlus Security +50.57%
#3 Starpower Starpower +34.89%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.29%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +21.03%
#7 Nockchain Nockchain +18.69%
#8 XMAQUINA XMAQUINA +17.84%
#9 Fake World Assets Fake World Assets +17.04%
#10 DMT-NAT DMT-NAT +14.82%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Kedudukan dalam Saham #33058
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Harga Saham
$0.3144463
Modal Pasaran
$8.48M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-2.55%
Negara
NO
Perdagangan Arctic Bioscience AS (ABS)

Kategori

Healthcare
Pendapatan untuk Arctic Bioscience AS (ABS)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Arctic Bioscience AS, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Arctic Bioscience AS dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE